Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

D Singh, Alberto Papi, Massimo Corradi, Ilona Pavlišová, Isabella Montagna, Catherine Francisco, Géraldine Cohuet, Stefano Vezzoli, Mario Scuri, Jorgen Vestbo

Division of Immunology, Immunity to Infection and Respiratory Medicine

Research output: Contribution to journal › Article › peer-review

988 Downloads (Pure)

2 results
- Title(descending)

Clinical trials in chronic obstructive pulmonary disease (COPD) advancing effective combination treatments
Singh, S. (Participant) & Vestbo, J. (Participant)
Impact: Health and wellbeing, Economic
Definitive multinational efficacy trials and pioneering ‘real-world’ evidence informing treatments and international strategy for managing chronic obstructive pulmonary disease (COPD)
Vestbo, J. (Participant), Singh, S. (Participant) & (Participant)
Impact: Health and wellbeing